WHO ICTRP trial
The feasibility study of miR-200c-3p in the diagnosis and treatment of…
ChiCTR-DDD-17013391 · Chinese Clinical Trial Registry (ChiCTR) · Not Recruiting
Key facts
| Trial ID | ChiCTR-DDD-17013391 |
|---|---|
| Public title | The feasibility study of miR-200c-3p in the diagnosis and treatment of endometrial carcinoma |
| Scientific title | The feasibility study of miR-200c-3p in the diagnosis and treatment of endometrial carcinoma |
| Primary sponsor | The Sixth Hospital of Shanghai |
| Registry | Chinese Clinical Trial Registry (ChiCTR) |
| Recruitment status | Not Recruiting |
| Study type | Diagnostic test |
| Phase | Diagnostic New Technique Clincal Study |
| Countries | China;China |
| Conditions | Endometrial carcinoma;Endometrial carcinoma |
| Interventions | Gold Standard:pathologic diagnosis;Index test:miR-200c-3p;;Gold Standard:pathologic diagnosis;Index test:miR-200c-3p |
| Registration date | Nov 15, 2017 |
| Target size | Target condition:0;Difficult condition:0 |
| Registry page | chictr.org.cn |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: